| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 176.24M | — |
| Operating expense | — | — |
| Net income | -67.23M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 08D.F returned +34.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +20.5% |
| 1 year | +34.7% |
| 5 years | +503.6% |
| All-time high | €105.15 (Jun 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 08D.F would be worth today ›No. Mirum Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Mirum Pharmaceuticals, Inc. is part of the Healthcare sector.
Mirum Pharmaceuticals, Inc. has a market cap of 4.89B EUR, based on the latest quote.
Mirum Pharmaceuticals, Inc. is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
